Description
Technical & Manufacturing Relevance:
Widely used for joint and cartilage support, aiding synthesis of glycosaminoglycans and proteoglycans essential for cartilage structure. Compared to glucosamine sulphate, the HCl form offers higher glucosamine content per dose and better stability with lower hygroscopicity, making it suitable for solid dosage manufacturing and combination joint-care formulations.
Applicable Dosage Forms:
Tablets, capsules, powders, sachets, liquids, combination joint-health formulations
Pharmacopoeial / Quality Notes:
Complies with USP / Ph. Eur. / BP (grade-dependent). Assayed for glucosamine content by HPLC or titration; tested for heavy metals, residual solvents, and microbial limits. Source declaration (shellfish vs fermentation) required for labeling and regulatory compliance.
Animal-origin Declaration:
Available in shellfish-derived and non-animal fermentation-derived (vegan) grades; allergen declaration mandatory for shellfish sources
Manufacturing Support:
Available for contract manufacturing, private/white labeling, customized joint-health formulations, complete regulatory documentation (CoA, MSDS, specifications, allergen statements), and export-ready compliance for resale and distribution worldwide
